XT
CAI

XTX Topco’s Caris Life Sciences CAI Stock Holding History

XTX Topco’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.43M Buy
136,488
+57,982
+74% +$1.04M 0.03% 923
2026
Q1 		$1.4M Buy
+78,506
New +$1.72M 0.02% 1145
2025
Q4 		– Sell
-28,081
Closed -$849K – 3976
2025
Q3 		$849K Buy
+28,081
New +$895K 0.04% 679

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

XTX Topco's CAI Position: Q2 2026 in Review

XTX Topco increased its Caris Life Sciences (CAI) stake by 74% in Q2 2026, buying an estimated $1.04M and bringing the position to 136,488 shares worth $2.43M. The position accounts for 0.03% of the portfolio, ranked #923.

XTX Topco first reported a position in CAI in Q3 2025 and has held it in 3 quarters since. 247 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • XTX Topco held 136,488 shares of Caris Life Sciences worth $2.43M as of Q2 2026.
  • XTX Topco bought 57,982 Caris Life Sciences shares in Q2 2026, an estimated $1.04M.
  • Caris Life Sciences made up 0.03% of XTX Topco's portfolio in Q2 2026, its #923 holding.
  • XTX Topco first reported a position in Caris Life Sciences in Q3 2025 and has held it in 3 quarters since.
  • 247 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.